VCP ScannerFree US Stock Screener & Financial AnalysisFree US Stock Screener
ScreenerThemes
DCF ValuationCalculate intrinsic value of US stocks
Market ValuationBuffett indicator, CAPE & macro gauges
Total ReturnSee dividends + price return history
DCA CalculatorSimulate recurring buys & compounding
Earnings
FAANG & Tech
AAPL vs MSFTNVDA vs AMDGOOGL vs META
Cloud & Cyber
CRM vs NOWCRWD vs PANWSNOW vs DDOG
Consumer & Auto
TSLA vs FAMZN vs WMTNFLX vs DIS
Finance & Crypto
JPM vs BACV vs MACOIN vs MSTR
Pharma & Energy
LLY vs NVOJNJ vs PFEXOM vs CVX
Compare Any Stocks...
WatchlistInsider
ScreenerThemes
Earnings
WatchlistInsider
LIXT
← Back to Screener
VCP ScannerFree US Stock Screener & Financial Analysis

Find stocks. Verify deeply. Act with conviction.

Data updated daily

Product

  • Screener
  • Themes
  • Valuation
  • Total Return
  • DCA Calculator
  • News
  • Earnings

Resources

  • Market Valuation
  • Compare
  • Insider Activity
  • Methodology
  • How It Works
  • Glossary
  • Learn

Get Ideas

Get weekly stock ideas — free

© 2026 VCP Scanner
AboutPrivacyTerms
Not financial advice. Do your own research.
ScreenerNewsCompareWatchlist
LIXTLixte Biotechnology Holdings, Inc.
$7.21$79M
Overview & Verdict
Overview
Valuation & Forecasts
Valuation ModelsEstimatesDCF Model
Price & Analyst Data
Analyst TargetsPrice HistoryTechnical Analysis
Financial Statements
Income StatementBalance SheetCash FlowRatios & Margins
Performance
P/E HistoryRevenue HistoryEarnings HistoryDividend HistoryTotal Return
Ownership
Holders
HomeStocksLIXTQuarterly Financials

Lixte Biotechnology Holdings, Inc. (LIXT) Quarterly Financials

120+ quarters historyFree accessUpdated daily

Lixte Biotechnology Holdings, Inc. (LIXT) quarterly income statement — complete revenue, gross profit & net income history

LIXT Income Statement

Income StatementBalance SheetCash FlowRatios
AnnualQuarterly
MetricQ1'26Q4'25Q3'25Q2'25Q1'25Q4'24Q3'24Q2'24Q1'24Q4'23Q3'23Q2'23Q1'23Q4'22Q3'22Q2'22Q1'22Q4'21Q3'21Q2'21
Sales/Revenue00000000000000000000
Revenue Growth %--------------------
Cost of Goods Sold00000000000000000000
COGS % of Revenue--------------------
Gross Profit00000000000000000000
Gross Margin %--------------------
Gross Profit Growth %--------------------
Operating Expenses1.99M1.82M1.8M774.81K706.94K613.5K983.26K1.01M966.88K1.03M1.02M1.67M1.37M1.63M1.48M1.55M1.65M2.02M1.24M1.73M
OpEx % of Revenue--------------------
Selling, General & Admin1.65M1.77M1.75M714.16K615.48K578.67K621.63K798.45K847.82K876.84K891.69K1.24M1.18M1.18M1.21M1.38M1.2M1.22M1.01M1.47M
SG&A % of Revenue--------------------
Research & Development333.38K52.12K50.7K60.65K91.46K34.83K361.63K210.71K119.06K149.07K132.49K427.46K189.09K453.62K272.39K164.81K458.45K803.65K227.18K262.42K
R&D % of Revenue--------------------
Other Operating Expenses00000000000000000000
Operating Income-1.99M-1.82M-1.8M-774.81K-706.94K-613.5K-983.26K-1.01M-966.88K-1.03M-1.02M-1.67M-1.37M-1.63M-1.48M-1.55M-1.65M-2.02M-1.24M-1.73M
Operating Margin %--------------------
Operating Income Growth %-181.13%-197.4%-83.2%23.22%26.88%40.2%4%39.57%29.43%37.16%30.73%-8.02%17.18%19.37%-19.45%10.77%4.11%-123.95%22.72%-364.02%
EBITDA-1.99M-2.54M-2.03M-773.86K00-984.98K-1.01M-964.14K0-1.02M-1.67M-1.36M0-1.48M-1.55M-1.65M0-1.24M-1.73M
EBITDA Margin %--------------------
EBITDA Growth %---106.13%23.13%100%-3.29%39.58%29.31%-30.99%-7.81%17.57%--19.15%10.77%4.09%100%22.66%-364.27%
D&A (Non-Cash Add-back)0000706.94K613.5K0001.03M0001.63M0002.02M00
EBIT-1.99M-2.54M-2.03M-773.86K-706.42K-613.5K-984.98K-1.01M-964.14K-1.03M-1.02M-1.67M-1.36M-1.63M-1.48M-1.55M-1.65M-2.02M-1.24M-1.73M
Net Interest Income3.37K-1.6K3.97K-1.45K-2.69K-3.91K388-1.92K-4.33K-6.2K5.53K7661.15K3.35K1.79K-436-2.38K-4.33K161-665
Interest Income3.37K2.15K4.43K3654415191.44K2.23K2.86K3.95K5.81K2.71K5.01K6.98K3.91K191109139161180
Interest Expense03.76K4571.81K3.13K4.43K1.05K4.15K7.19K10.14K2791.95K3.86K3.63K2.12K6272.49K4.47K0845
Other Income/Expense-201-719.38K-229.41K-864-2.62K-4.2K-2.77K-1.76K-4.44K-6.34K5.42K1.64K2.49K1.31K492-294-2.57K-4.41K-1K-571
Pretax Income-1.99M-2.54M-2.03M-775.67K-709.55K-617.69K-986.03K-1.01M-971.32K-1.03M-1.02M-1.67M-1.37M-1.63M-1.48M-1.55M-1.66M-2.03M-1.24M-1.73M
Pretax Margin %--------------------
Income Tax00000000000000000000
Effective Tax Rate %0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%
Net Income-1.92M-2.54M-2.03M-775.67K-709.55K-617.69K-986.03K-1.01M-971.32K-1.03M-1.02M-1.67M-1.37M-1.63M-1.48M-1.55M-1.66M-2.03M-1.24M-1.73M
Net Margin %--------------------
Net Income Growth %-171.11%-311.84%-105.95%23.27%26.95%40.16%3.21%39.41%28.98%36.72%31.07%-7.89%17.46%19.61%-19.32%10.78%4.07%-123.76%22.66%-364.5%
Net Income (Continuing)-1.99M-2.54M-2.03M-775.67K-709.55K-617.69K-986.03K-1.01M-971.32K-1.03M-1.02M-1.67M-1.37M-1.63M-1.48M-1.55M-1.66M-2.03M-1.24M-1.73M
Discontinued Operations00000000000000000000
Minority Interest1.23M1.3M000000000000000000
EPS (Diluted)-0.18-0.33-0.33-0.29-0.29-0.27-0.44-0.45-0.43-0.46-0.49-1.00-0.82-0.98-0.89-0.95-1.20-1.48-0.90-1.27
EPS Growth %37.93%-22.22%25%35.56%32.56%41.3%10.2%55%47.56%53.06%44.94%-5.26%31.67%33.78%1.11%25.2%11.11%-89.74%37.06%-284.85%
EPS (Basic)-0.18-0.33-0.33-0.29-0.29-0.27-0.44-0.45-0.43-0.46-0.49-1.00-0.82-0.98-0.89-0.95-1.20-1.48-0.90-1.27
Diluted Shares Outstanding10.89M48.41M6.17M2.72M2.47M2.25M2.25M2.25M2.25M2.25M2.07M1.67M1.66M1.67M1.66M1.62M1.37M1.37M1.37M1.36M
Basic Shares Outstanding10.89M48.41M6.17M2.72M2.47M2.25M2.25M2.25M2.25M2.25M2.07M1.67M1.66M1.67M1.66M1.62M1.37M1.37M1.37M1.36M
Dividend Payout Ratio--------------------